
Thrombotic risk assessment and analytical performance of the chemiluminescent analyzer IDS-iSYS for the detection of anti-cardiolipin and anti-beta 2 glycoprotein I autoantibodies
Keywords: Anti-cardiolipin; Anti-β2GPI; Thrombosis; Anti-phospholipid syndrome; Chemiluminescence;